SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: William Strop who wrote (948)1/5/1999 1:45:00 AM
From: Mike McFarland  Respond to of 1972
 
Over the holidays I went through all
my father in law's business magazines.
I found in the November issue of Kiplinger's
some favorable comments about VICL. It caught
my eye because I have small positions in Ariad
(even smaller after today) and Targeted Genetics.

Anyway, I have to go through this thread and
the yahoo thread and do a little catch up
work on this one...but if anybody can give
me a quick answer I'd appreciated it: Does
Vical have any proprietary methods for
generating AAV, and why is it so hard to
make quantities of the virus?

Thank you for any thoughts you folks might have.

--Mike



To: William Strop who wrote (948)1/5/1999 7:54:00 AM
From: Scott H. Davis  Read Replies (1) | Respond to of 1972
 
Thanks Bill. Unfortunately without a name reference, only informed investors will make the connection. May not spur a lot of new buys, but could cause folks to add to positions. Anyway, still good news IMSCO Scott


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News